Your browser doesn't support javascript.
loading
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
Yamasoba, Daichi; Uriu, Keiya; Plianchaisuk, Arnon; Kosugi, Yusuke; Pan, Lin; Zahradnik, Jiri; Ito, Jumpei; Sato, Kei.
Afiliación
  • Yamasoba D; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Faculty of Medicine, Kobe University, Kobe, Japan.
  • Uriu K; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Plianchaisuk A; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan.
  • Kosugi Y; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Pan L; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
  • Zahradnik J; First Medical Faculty at Biocev, Charles University, Vestec-Prague, Czechia.
  • Ito J; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan.
  • Sato K; Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; International Research Center for Infectious Diseases, The University of Tokyo, Tokyo, Japan; International Vaccine Design Center, The University of Tokyo, Tokyo, Japan; The Institute of M
Lancet Infect Dis ; 23(6): 655-656, 2023 06.
Article en En | MEDLINE | ID: mdl-37148902
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Japón